Alnylam Pharmaceuticals
ALNY
#636
Rank
NZ$55.19 B
Marketcap
$427.91
Share price
-1.24%
Change (1 day)
52.60%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: NZ$55.19 Billion

As of December 2024 Alnylam Pharmaceuticals has a market cap of NZ$55.19 Billion. This makes Alnylam Pharmaceuticals the world's 636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$55.19 B45.31%
2023NZ$37.98 B-17.52%
2022NZ$46.05 B55.09%
2021NZ$29.69 B41.89%
2020NZ$20.92 B9.08%
2019NZ$19.18 B74.45%
2018NZ$10.99 B-38.01%
2017NZ$17.74 B282.49%
2016NZ$4.63 B-60.37%
2015NZ$11.70 B22.46%
2014NZ$9.55 B91.63%
2013NZ$4.98 B328.31%
2012NZ$1.16 B160.99%
2011NZ$0.44 B-17.55%
2010NZ$0.54 B-46.68%
2009NZ$1.01 B-42.49%
2008NZ$1.76 B14.01%
2007NZ$1.54 B37.54%
2006NZ$1.12 B198.59%
2005NZ$0.37 B86.71%
2004NZ$0.20 B

End of Day market cap according to different sources

On Dec 4th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

NZ$55.88 Billion
by Yahoo Finance info icon info icon
NZ$55.88 Billion
by CompaniesMarketCap info icon info icon
NZ$55.88 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$4.76 B-91.36%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$142.82 B 158.78%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$20.64 B-62.59%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.80 B-96.72%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.16 B-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$349.48 B 533.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$207.41 B 275.81%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$34.45 B-37.58%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel